Tweenvest Stocks

Atomo Diagnostics Limited (ASX: AT1)

Health Care · Health Care Equipment & Supplies · AU

AU$0.02

-2.70% today · -30.8% 1Y

Atomo Diagnostics Limited (ASX: AT1) operates in the Health Care Equipment & Supplies industry within the Health Care sector. The company is valued at $11.34M and employs 85 people.

Over the last twelve months the share price has lost 30.8%, trading between 0.02 and 0.05.

Tweenvest scores Atomo Diagnostics Limited across four factors: quality 39/100, value 59/100, growth 100/100. Its strongest factor is growth.

AT1 price history

Not enough price history to draw a chart yet.

Key figures

Market cap
$11.34M
Revenue (TTM)
$3.69M
P/E
—
EPS
-0.00
Dividend yield
—
Beta (5Y)
1.28
52-week high
AU$0.05
52-week low
AU$0.02
Avg volume (3M)
—
Shares outstanding
902.43M
Employees
85
Next earnings
—

About Atomo Diagnostics Limited

Established in 2010 and based in Leichhardt, Australia, Atomo Diagnostics Limited is a global enterprise focused on the innovation and commercialization of medical devices. The company provides swift-result diagnostic tools designed for various applications, including COVID-19 detection, HIV screening, pregnancy confirmation, and assessing respiratory conditions.

ISIN
AU0000080327
Founded
2010
Listed since
Apr 16, 2020
Exchange
Australian Securities Exchange
Currency
AUD
CompanyMarket capPriceDay
MedX Health CorpTSXV: MDX$11.49MCA$0.050.00%
Ventripoint Diagnostics Ltd.TSXV: VPT$11.49MCA$0.090.00%
Taiwan Advanced Nanotech Inc.TPEX: 6797$11.47MNT$12.20+6.09%
ViroGates A/SCPSE: VIRO$11.40MDkr8.40+2.44%
EPS Bio Technology Corp.TPEX: 4183$11.06MNT$14.75+2.79%
PZ Cormay S.A.WSE: CRM$10.96Mzł0.51-1.92%
Joyzyme Group LimitedSEHK: 8622$10.84MHK$0.17-4.62%
Arcoma ABOM: ARCOMA$10.82MSkr7.58+0.26%

Browse every Health Care Equipment & Supplies company →

Figures last refreshed Oct 11, 2026.